Building pharmacogenetics into a pharmacovigilance program in Singapore: using serious skin rash as a pilot study
{{output}}
To study the possible genetic associations with adverse drug reactions (ADR), the Singapore Health Sciences Authority (HSA) has piloted a program to collect DNA and phenotype data of ADR cases as part of its pharmacovigilance program. Between 2009 and 2012, HS... ...
